ClinicalTrials.gg
Not yet recruitingNCT06861699Updated Mar 6, 2025

Blood Flow Technique Effect on the Muscle Mechanics

An observational study in Biceps and Muscle Rigidity, sponsored by Okan University. Not yet recruiting. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-06.

Sponsored by Okan University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
57
Ages
18 Years to 25 Years
Sex
All
01

Study summary

This study will be a study in which we take measurements with the myotonPRO device to determine whether the resistant exercises performed without the blood flow restrictive technique and with the blood flow restrictive technique affect the biceps muscle of the participants, who were divided into groups by randomization method after determining the 1 max repetition you can lift.

02

Conditions studied

  • Biceps
  • Muscle Rigidity

Browse trials for

03

In context

Muscle Rigidity

31 studies on the registry are indexed under Muscle Rigidity; 9 are open to participants now.

This study's planned enrollment of 57 is close to the median of 60 across 11 observational studies indexed under Muscle Rigidity.

Browse Muscle Rigidity studies →

Lead sponsor

Okan University is the lead sponsor of 97 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

generally college students

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being a healthy male or female volunteer between 18 and 35 (who has not participated in any resistance training program for at least 6 months).
  • Being right-hand dominant according to the results of the Edinburgh Handedness Inventory.

Exclusion criteria

Exclusion Criteria:

  • Having a history of biceps musculoskeletal injury.
  • Having any condition that prevents participation in resistance exercise.
  • Having cardiovascular disease.
  • Using medication for blood pressure control.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
57 participants (estimated)
Patient registry
No

Groups and cohorts

  • progressive resistance exercise group with bfr (%80)

    Participants in this group will perform progressive resistance exercises with 80% blood flow restriction (BFR) exposure, while muscle mechanical properties will be monitored and recorded during the process.

  • progressive resistance exercise group with bfr (%20)

    Participants in this group will perform progressive resistance exercises with 20% blood flow restriction (BFR) exposure, while muscle mechanical properties will be monitored and recorded during the process.

  • Non-Blood Flow Restriction Group

    Participants in this group will perform progressive resistance exercises without applying the blood flow restriction (BFR) technique, while muscle mechanical properties will be monitored and recorded during the process."

06

What researchers measure

Primary outcomes

  1. muscle mechanics test

    Time frame: Single assessment at baseline and one, two and three days after with measurement

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Mar 2025; primary completion for Apr 2025, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2025
First posted
Mar 6, 2025
StartEst.
Mar 3, 2025
Primary completionEst.
Apr 5, 2025
CompletionEst.
May 1, 2025
Last update
Mar 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06861699
Lead sponsor
Okan University
Responsible party
Melis Destan (Assistant Professor, Okan University) — Principal investigator
First posted
Mar 6, 2025
Start date
Mar 3, 2025 (estimated)
Primary completion
Apr 5, 2025 (estimated)
Completion
May 1, 2025 (estimated)
Last update
Mar 6, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion